# Bioequivalence Study of Ibuprofen 400 mg/10 mL Oral Suspension vs. MOMENTACT 400 mg Film-coated Tablet

> **NCT02902302** · PHASE1 · COMPLETED · sponsor: **Aziende Chimiche Riunite Angelini Francesco S.p.A** · enrollment: 60 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Ibuprofen 400 mg/10 mL oral suspension
- **DRUG:** MOMENT 400 mg coated tablet

## Key facts

- **NCT ID:** NCT02902302
- **Lead sponsor:** Aziende Chimiche Riunite Angelini Francesco S.p.A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2016-06
- **Final completion:** 2016-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2016-09-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02902302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02902302, "Bioequivalence Study of Ibuprofen 400 mg/10 mL Oral Suspension vs. MOMENTACT 400 mg Film-coated Tablet". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02902302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*